Cardiological society of India position statement on COVID-19 and heart failure

2020

2020

Meo, 2020, Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV, Eur Rev Med Pharmacol Sci, 24, 2012

Callaway, 2020, The coronavirus pandemic in five powerful charts, Nature, 579, 482, 10.1038/d41586-020-00758-2

Wang, 2020, Review and prospect of pathological features of corona virus disease, Fa Yi Xue Za Zhi, 36, 16

Wu, 2020, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention, J Am Med Assoc, 10.1001/jama.2020.2648

Bansal, 2020, Cardiovascular disease and COVID-19, Diabetes Metab Syndr, 14, 247, 10.1016/j.dsx.2020.03.013

Li, 2020, Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China, Clin Res Cardiol Off J Ger Card Soc, 10.1007/s00392-020-01626-9

Guo, 2020, Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19), JAMA Cardiol, 10.1001/jamacardio.2020.1017

Ruan, 2020, Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China, Intensive Care Med

Shi, 2020, Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China, JAMA Cardiol, 10.1001/jamacardio.2020.0950

Akhmerov, 2020, COVID-19 and the heart, Circ Res, 10.1161/CIRCRESAHA.120.317055

Zhou, 2020, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet, 395, 1054, 10.1016/S0140-6736(20)30566-3

Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet Lond Engl, 395, 497, 10.1016/S0140-6736(20)30183-5

Zhou, 2003, Productivity losses from injury in China, Inj Prev J Int Soc Child Adolesc Inj Prev, 9, 124, 10.1136/ip.9.2.124

Wang, 2020, Angiotensin converting Enzyme 2: a double-edged sword, Circulation, 10.1161/CIRCULATIONAHA.120.047049

Hu, 2020, Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin, Eur Heart J, 10.1093/eurheartj/ehaa190

Inciardi, 2020, Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19), JAMA Cardiol, 10.1001/jamacardio.2020.1096

Meyer, 2020, Typical takotsubo syndrome triggered by SARS-CoV-2 infection, Eur Heart J, 10.1093/eurheartj/ehaa306

Chen, 2020, Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study, BMJ, 26, 368

Dong, 2020, End-stage heart failure with COVID-19: strong evidence of myocardial injury by 2019-nCoV, JACC Heart Fail

Zeng, 2020, First case of COVID-19 complicated with fulminant myocarditis: a case report and insights, Infection, 10.1007/s15010-020-01424-5

Kochi, 2020, Cardiac and arrhythmic complications in patients with COVID-19, J Cardiovasc Electrophysiol, 10.1111/jce.14479

Lakkireddy, 2020, Circulation

FGP, 2020, Catheterization laboratory considerations during the coronavirus (COVID-19) pandemic: from ACC's interventional Council and SCAI, J Am Coll Cardiol

Kerkar, 2020

Chapman, 2020, High-sensitivity cardiac troponin can Be an ally in the fight against COVID-19, Circulation, 10.1161/CIRCULATIONAHA.120.047008

Henry, 2020, Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis, Clin Chem Lab Med, 10.1515/cclm-2020-0369

Clerkin, 2020, Coronavirus disease 2019 (COVID-19) and cardiovascular disease, Circulation

Lippi, 2020, Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis, Prog Cardiovasc Dis, 10.1016/j.pcad.2020.03.001

2020, Covid-19: ibuprofen should not Be used for managing symptoms, say doctors and scientists, BMJ, 368

2020

2020

2020

2020

Duan, 2020, Effectiveness of convalescent plasma therapy in severe COVID-19 patients, Proc Natl Acad Sci U S A, 10.1073/pnas.2004168117

Zhang, 2020, Association of inpatient use of angiotensin converting Enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19, Circ Res

2020

2020

Hendren Nicholas, 2020, Description and proposed management of the acute COVID-19 cardiovascular syndrome, Circulation, 10.1161/CIRCULATIONAHA.120.047349

Acanfora, 2020, Neprilysin inhibitor–angiotensin II receptor blocker combination (sacubitril/valsartan): rationale for adoption in SARS-CoV-2 patients, Eur Heart J - Cardiovasc Pharmacother, 10.1093/ehjcvp/pvaa028

2020

Nord, 2004, Hydroxychloroquine cardiotoxicity in systemic lupus erythematosus: a report of 2 cases and review of the literature, Semin Arthritis Rheum, 33, 336, 10.1016/j.semarthrit.2003.09.012

Ren, 2020, Epidemiological and clinical characteristics OF heart transplant recipients during the 2019 coronavirus outbreak IN Wuhan, China: a descriptive survey report, J Heart Lung Transplant, 10.1016/j.healun.2020.03.008

Li, 2020, First cases of COVID-19 in heart transplantation from China, J Heart Lung Transplant

2020

Wu, 2020, Co-infection with SARS-CoV-2 and influenza A virus in patient with pneumonia, China, Emerg Infect Dis, 26

Maron, 2015, Circulation, 132, e273

Huang, 2020, Cardiac involvement in recovered COVID-19 patients identified by magnetic resonance imaging, J Am Coll Cardiol Img, 10.1016/j.jcmg.2020.05.004